Ana Clara Patrício Barbosa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ana Clara Patrício Barbosa has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Camila Carreira Brito
Universidade federal do Pará
3 shared publications - Giovanna Gilioli da Costa Nunes
Universidade federal do Pará
3 shared publications - Jerffson Carvalho de Souza
Universidade federal do Pará
3 shared publications - João Victor Souza de Barros
Universidade federal do Pará
3 shared publications - João Vitor Smith da Silva
Universidade federal do Pará
3 shared publications - Laura Patrícia Albarello Gellen
Universidade federal do Pará
3 shared publications
Latest Publications
- 2 January 2026
- Published by Revista Brasileira De Cancerologia (RBC) in Revista Brasileira de Cancerologia
- Vol. 72 (1) , e025363
The Role of ERCC1, BACH1 and NR5A2 Single-Nucleotide Polymorphisms with Pancreatic Cancer Risk and Global Epidemiology: Literature Systematic Review
Introduction: Pancreatic cancer is one of the most aggressive malignancies, ranking as the twelfth most common cancer and the sixth leading cause of cancer-related deaths worldwide. Its etiology is multifactorial, involving both genetic and non-genetic factors. Objective: Investigate the relationship between epidemiological data on global incidence and mortality of pancreatic cancer and specific genetic variations known as single nucleotide polymorphisms (SNPs). Method: A total of 253 SNPs were analyzed, identified through genome-wide association studies (GWAS). Allele frequencies were obtained from global population databases. Pearson’s correlation analysis was utilized to evaluate the relationships between SNPs frequencies, incidence, and mortality rates. Results: The results identified 16 significant SNPs (p<0.05), among which rs2816938, rs372883, and rs2236575 were highly significant (p<0.001). These variants were primarily associated with higher mortality rates, particularly in European and American populations, while African and Southeast Asian populations showed lower SNPs frequencies and lower mortality rates. The findings suggest that genetic predisposition plays a crucial role in pancreatic cancer susceptibility and progression. Conclusion: The correlation between SNPs frequencies and epidemiological data reinforces the influence of population-specific genetic risk factors, highlighting the importance of personalized approaches in screening, prevention, and treatment strategies.
- 2 January 2026
- Published by Revista Brasileira De Cancerologia (RBC) in Revista Brasileira de Cancerologia
- Vol. 72 (1) , e025363
The Role of ERCC1, BACH1 and NR5A2 Single-Nucleotide Polymorphisms with Pancreatic Cancer Risk and Global Epidemiology: Literature Systematic Review
Introduction: Pancreatic cancer is one of the most aggressive malignancies, ranking as the twelfth most common cancer and the sixth leading cause of cancer-related deaths worldwide. Its etiology is multifactorial, involving both genetic and non-genetic factors. Objective: Investigate the relationship between epidemiological data on global incidence and mortality of pancreatic cancer and specific genetic variations known as single nucleotide polymorphisms (SNPs). Method: A total of 253 SNPs were analyzed, identified through genome-wide association studies (GWAS). Allele frequencies were obtained from global population databases. Pearson’s correlation analysis was utilized to evaluate the relationships between SNPs frequencies, incidence, and mortality rates. Results: The results identified 16 significant SNPs (p<0.05), among which rs2816938, rs372883, and rs2236575 were highly significant (p<0.001). These variants were primarily associated with higher mortality rates, particularly in European and American populations, while African and Southeast Asian populations showed lower SNPs frequencies and lower mortality rates. The findings suggest that genetic predisposition plays a crucial role in pancreatic cancer susceptibility and progression. Conclusion: The correlation between SNPs frequencies and epidemiological data reinforces the influence of population-specific genetic risk factors, highlighting the importance of personalized approaches in screening, prevention, and treatment strategies.
- Open Access
- 2 January 2026
- Published by Revista Brasileira De Cancerologia (RBC) in Revista Brasileira de Cancerologia
- Vol. 72 (1) , e025363-025363
El Papel de los Polimorfismos de Núcleotido Único en los Genes ERCC1, BACH1 y NR5A2 en la Susceptibilidad al Cáncer de Páncreas y la Epidemiología Global: Revisión Sistemática de la Literatura
Introducción: El cáncer de páncreas es una de las neoplasias malignas más agresivas, ocupando el duodécimo lugar entre los cánceres más comunes, y la sexta causa principal de muertes relacionadas con el cáncer a nivel mundial. Su etiología es multifactorial, involucrando factores genéticos y no genéticos. Objetivo: Investigar la relación entre los datos epidemiológicos sobre la incidencia y mortalidad global del cáncer de páncreas y variaciones genéticas específicas conocidas como polimorfismos de un solo nucleótido (SNP). Método: Se analizaron 253 SNP, identificados a través de estudios de asociación del genoma completo (GWAS). Las frecuencias alélicas se obtuvieron de bases de datos de poblaciones globales. Utilizando el análisis de correlación de Pearson, se evaluaron las relaciones entre las frecuencias de los SNP, la incidencia y las tasas de mortalidad. Resultados: Los resultados identificaron 16 SNP significativos (p<0,05), entre los cuales rs2816938, rs372883 y rs2236575 fueron altamente significativos (p<0,001). Estas variantes se asociaron principalmente con tasas de mortalidad más elevadas, particularmente en poblaciones europeas y americanas, mientras que las poblaciones africanas y del Sudeste Asiático mostraron frecuencias de SNP más bajas y tasas de mortalidad más reducidas. Los hallazgos sugieren que la predisposición genética desempeña un papel crucial en la susceptibilidad y progresión del cáncer de páncreas. Conclusión: La correlación entre las frecuencias de SNP y los datos epidemiológicos refuerza la influencia de los factores de riesgo genéticos específicos de cada población, destacando la importancia de enfoques personalizados en las estrategias de detección, prevención y tratamiento.
- 2 January 2026
- Published by Revista Brasileira De Cancerologia (RBC) in Revista Brasileira de Cancerologia
- Vol. 72 (1) , e025363-025363
Open AccessEl Papel de los Polimorfismos de Núcleotido Único en los Genes ERCC1, BACH1 y NR5A2 en la Susceptibilidad al Cáncer de Páncreas y la Epidemiología Global: Revisión Sistemática de la Literatura
Introducción: El cáncer de páncreas es una de las neoplasias malignas más agresivas, ocupando el duodécimo lugar entre los cánceres más comunes, y la sexta causa principal de muertes relacionadas con el cáncer a nivel mundial. Su etiología es multifactorial, involucrando factores genéticos y no genéticos. Objetivo: Investigar la relación entre los datos epidemiológicos sobre la incidencia y mortalidad global del cáncer de páncreas y variaciones genéticas específicas conocidas como polimorfismos de un solo nucleótido (SNP). Método: Se analizaron 253 SNP, identificados a través de estudios de asociación del genoma completo (GWAS). Las frecuencias alélicas se obtuvieron de bases de datos de poblaciones globales. Utilizando el análisis de correlación de Pearson, se evaluaron las relaciones entre las frecuencias de los SNP, la incidencia y las tasas de mortalidad. Resultados: Los resultados identificaron 16 SNP significativos (p<0,05), entre los cuales rs2816938, rs372883 y rs2236575 fueron altamente significativos (p<0,001). Estas variantes se asociaron principalmente con tasas de mortalidad más elevadas, particularmente en poblaciones europeas y americanas, mientras que las poblaciones africanas y del Sudeste Asiático mostraron frecuencias de SNP más bajas y tasas de mortalidad más reducidas. Los hallazgos sugieren que la predisposición genética desempeña un papel crucial en la susceptibilidad y progresión del cáncer de páncreas. Conclusión: La correlación entre las frecuencias de SNP y los datos epidemiológicos refuerza la influencia de los factores de riesgo genéticos específicos de cada población, destacando la importancia de enfoques personalizados en las estrategias de detección, prevención y tratamiento.
- Open Access
- 1 October 2025
- Published by Revista Brasileira De Cancerologia (RBC) in Revista Brasileira de Cancerologia
- Vol. 72 (1)
The Role of ERCC1, BACH1 and NR5A2 Single-Nucleotide Polymorphisms with Pancreatic Cancer Risk and Global Epidemiology: Literature Systematic Review
Introduction: Pancreatic cancer is one of the most aggressive malignancies, ranking as the twelfth most common cancer and the sixth leading cause of cancer-related deaths worldwide. Its etiology is multifactorial, involving both genetic and non-genetic factors. Objective: Investigate the relationship between epidemiological data on global incidence and mortality of pancreatic cancer and specific genetic variations known as single nucleotide polymorphisms (SNPs). Method: A total of 253 SNPs were analyzed, identified through genome-wide association studies (GWAS). Allele frequencies were obtained from global population databases. Pearson’s correlation analysis was utilized to evaluate the relationships between SNPs frequencies, incidence, and mortality rates. Results: The results identified 16 significant SNPs (p<0.05), among which rs2816938, rs372883, and rs2236575 were highly significant (p<0.001). These variants were primarily associated with higher mortality rates, particularly in European and American populations, while African and Southeast Asian populations showed lower SNPs frequencies and lower mortality rates. The findings suggest that genetic predisposition plays a crucial role in pancreatic cancer susceptibility and progression. Conclusion: The correlation between SNPs frequencies and epidemiological data reinforces the influence of population-specific genetic risk factors, highlighting the importance of personalized approaches in screening, prevention, and treatment strategies.
- 1 October 2025
- Published by Revista Brasileira De Cancerologia (RBC) in Revista Brasileira de Cancerologia
- Vol. 72 (1)
Open AccessThe Role of ERCC1, BACH1 and NR5A2 Single-Nucleotide Polymorphisms with Pancreatic Cancer Risk and Global Epidemiology: Literature Systematic Review
Introduction: Pancreatic cancer is one of the most aggressive malignancies, ranking as the twelfth most common cancer and the sixth leading cause of cancer-related deaths worldwide. Its etiology is multifactorial, involving both genetic and non-genetic factors. Objective: Investigate the relationship between epidemiological data on global incidence and mortality of pancreatic cancer and specific genetic variations known as single nucleotide polymorphisms (SNPs). Method: A total of 253 SNPs were analyzed, identified through genome-wide association studies (GWAS). Allele frequencies were obtained from global population databases. Pearson’s correlation analysis was utilized to evaluate the relationships between SNPs frequencies, incidence, and mortality rates. Results: The results identified 16 significant SNPs (p<0.05), among which rs2816938, rs372883, and rs2236575 were highly significant (p<0.001). These variants were primarily associated with higher mortality rates, particularly in European and American populations, while African and Southeast Asian populations showed lower SNPs frequencies and lower mortality rates. The findings suggest that genetic predisposition plays a crucial role in pancreatic cancer susceptibility and progression. Conclusion: The correlation between SNPs frequencies and epidemiological data reinforces the influence of population-specific genetic risk factors, highlighting the importance of personalized approaches in screening, prevention, and treatment strategies.